Pityriasis lichenoides chronica-like drug eruption developing during pembrolizumab treatment for metastatic melanoma.

Mohammed Milhem
Mohammed Milhem
University of Iowa
Brian L Swick
Brian L Swick
University of Iowa
United States
Vincent Liu
Vincent Liu
The University of Hong Kong
Hong Kong

JAAD Case Rep 2016 Jul 17;2(4):343-5. Epub 2016 Aug 17.

Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa; Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
Source Status
Web SearchFound
Publisher SiteFound
http://dx.doi.org/10.1016/j.jdcr.2016.06.012DOI ListingPossible
July 2016
6 Reads

Similar Publications

The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girl.

Br J Dermatol 1997 Dec;137(6):983-7

Department of Dermatology, University of Frankfurt Medical School, Germany.

Parakeratosis variegata is a rare disorder with unknown aetiology. In a few cases it arises from benign skin diseases such as pityriasis lichenoides et varioliformis acuta (Mucha Habermann disease) or pityriasis lichenoides chronica. However, transformation into malignant diseases such as cutaneous T-cell lymphoma has been observed. Read More

View Article
December 1997

Phototherapy for Pityriasis Lichenoides in the Pediatric Population: A Review of the Published Literature.

Am J Clin Dermatol 2016 Dec;17(6):583-591

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1475 NW 12th Ave., Miami, FL, 33136, USA.

Background: Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (pityriasis lichenoides et varioliformis acuta) or the chronic form (pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective.

Objective: The goal of this study was to review the use of phototherapy for treating PL in the pediatric population. Read More

View Article
December 2016

[Photochemotherapy for pityriasis lichenoides: 3 cases].

Ann Dermatol Venereol 2004 Feb;131(2):201-3

Service de Dermatologie, Hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75010 Paris.

Background: Pityriasis lichenoides is a rare cutaneous disorder of unknown origin that mainly affects children and young people. The disease consists of two variants: pityriasis lichenoides et varioliformis acuta, characterized by papular lesions evolving into necrosis and pityriasis lichenoides chronica characterized by scaly papules that may last from several months to several years. Various types of therapy have been proposed for pityriasis lichenoides, to our knockledge, photochemotherapy has never been used. Read More

View Article
February 2004

Pityriasis lichenoides chronica associated with herpes simplex virus type 2.

Case Rep Dermatol Med 2012 2;2012:737428. Epub 2012 Dec 2.

Departments of Dermatology, Hospital Clínico of Valencia, University of Valencia, Avenida Blasco Ibáñez 17, 46010 Valencia, Spain.

Introduction. Pityriasis lichenoides is a rare, acquired spectrum of skin conditions of an unknown etiology. Case Report. Read More

View Article
December 2012